Endava is trading at $1.80, down 10.00%, as investors continue reacting to the accounting investigation following the September 21, 2026 disclosure that CFO Mark Thurston was placed on administrative leave.
- The decline extends Endavaβs September 23, 2026 close of $2.00.
- The independent investigation follows auditor concerns about accounting treatment for certain customer and supplier agreements. Conor McShane of AlixPartners was appointed interim CFO.
- The broader market is weaker, but company-specific concerns dominate.